Zentek Ltd. (NASDAQ:ZTEK) Short Interest Update

Zentek Ltd. (NASDAQ:ZTEK) was the target of a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 58,700 shares, a decrease of 60.3% from the February 28th total of 148,000 shares. Based on an average daily volume of 45,300 shares, the days-to-cover ratio is presently 1.3 days. Approximately 0.1% of the shares of the stock are sold short.

Zentek Price Performance

Shares of NASDAQ:ZTEK opened at $1.17 on Friday. The firm has a market cap of $122.14 million, a price-to-earnings ratio of -16.71 and a beta of 1.30. The firm has a fifty day moving average price of $1.06 and a 200 day moving average price of $0.96. Zentek has a fifty-two week low of $0.50 and a fifty-two week high of $1.31. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.48 and a current ratio of 1.83.

Zentek (NASDAQ:ZTEK) last issued its quarterly earnings data on Wednesday, February 12th. The company reported ($0.01) earnings per share for the quarter. Zentek had a negative net margin of 16,555.32% and a negative return on equity of 58.13%.

Hedge Funds Weigh In On Zentek

Large investors have recently bought and sold shares of the business. Anson Funds Management LP purchased a new stake in shares of Zentek in the 4th quarter worth approximately $145,000. Scotia Capital Inc. increased its position in shares of Zentek by 5.7% in the fourth quarter. Scotia Capital Inc. now owns 958,771 shares of the company’s stock valued at $867,000 after buying an additional 51,744 shares in the last quarter. Finally, Two Sigma Securities LLC purchased a new position in Zentek in the 4th quarter valued at about $31,000. Hedge funds and other institutional investors own 0.77% of the company’s stock.

Zentek Company Profile

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.